Deciding whether to treat HCV involves weighing several factors. For some people, treatment is needed now due to medical necessity, while others may wait for newer therapies. It is also possible to stop treatment after 12 weeks if it does not appear to be effective. The advantages of treatment include clearing the virus, improving liver health by reducing inflammation and potentially reversing fibrosis. Treatment also prevents transmitting HCV to others and removes the risk of mother-to-infant transmission. It can reduce liver toxicity when taking HIV drugs and lasts 12-18 months rather than being lifelong. Treatment may decrease long-term risks like liver cancer even if the virus is not cleared.
Deciding whether to treat HCV involves weighing several factors. For some people, treatment is needed now due to medical necessity, while others may wait for newer therapies. It is also possible to stop treatment after 12 weeks if it does not appear to be effective. The advantages of treatment include clearing the virus, improving liver health by reducing inflammation and potentially reversing fibrosis. Treatment also prevents transmitting HCV to others and removes the risk of mother-to-infant transmission. It can reduce liver toxicity when taking HIV drugs and lasts 12-18 months rather than being lifelong. Treatment may decrease long-term risks like liver cancer even if the virus is not cleared.
Deciding whether to treat HCV involves weighing several factors. For some people, treatment is needed now due to medical necessity, while others may wait for newer therapies. It is also possible to stop treatment after 12 weeks if it does not appear to be effective. The advantages of treatment include clearing the virus, improving liver health by reducing inflammation and potentially reversing fibrosis. Treatment also prevents transmitting HCV to others and removes the risk of mother-to-infant transmission. It can reduce liver toxicity when taking HIV drugs and lasts 12-18 months rather than being lifelong. Treatment may decrease long-term risks like liver cancer even if the virus is not cleared.
Deciding whether to treat HCV involves weighing several factors. For some people, treatment is needed now due to medical necessity, while others may wait for newer therapies. It is also possible to stop treatment after 12 weeks if it does not appear to be effective. The advantages of treatment include clearing the virus, improving liver health by reducing inflammation and potentially reversing fibrosis. Treatment also prevents transmitting HCV to others and removes the risk of mother-to-infant transmission. It can reduce liver toxicity when taking HIV drugs and lasts 12-18 months rather than being lifelong. Treatment may decrease long-term risks like liver cancer even if the virus is not cleared.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 1
Deciding whether to treat HCV
Deciding whether or not to treat hepatitis C is an individual and
complex decision. Some people really need HCV treatment now. It may be a bridge until newer, more effective, and less toxic therapies are available. Medical need is one of several other factors to be taken into account. You may know early on whether it is necessary to use the full course of HCV treatment. If, after 12 weeks, it looks like treatment will not work for you, you may decide to stop.
Advantages of using HCV treatment
You can clear the virus. Treatment can improve liver health by reducing inflammation. It may also reverse fibrosis. This can happen even in people who do not clear the virus, although less often. It will stop the risk of passing HCV to sexual and drug-using partners. Clearing the virus removes the risk of mother-to-infant transmission. Treating HCV before starting HIV treatment will reduce the risk of liver toxicity from HIV drugs. The treatment period is likely to be only 12 to 18 months, not lifelong. Treatment may reduce the risk of long-term complications, including liver cancer, even in people who do not clear HCV.